Depository of News

Amplia gets nod for new cancer drug trial ahead of US push

smh.com.au · health

Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Read full article →